An interventional study of Gong's Mobilization and Gong's Mobilization and Niel-Asher technique in Adhesive Capsulitis, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-05.
Sponsored by Riphah International University · Not applicable, Interventional, and Treatment
Adhesive Capsulitis causes a progressive tightening of the glenohumeral joint capsule, restricting both active and passive movements and resulting in functional impairments. Joint mobilization is an essential component of physical therapy for managing adhesive capsulitis. Two new techniques are emerging in the treatment of Adhesive capsulitis; one of them is called Gong's Mobilization. This technique emphasizes correcting positional faults by applying controlled, dynamic movements to the glenohumeral joint. The other technique, known as Niel-Asher technique is a five-step trigger point therapy which offers a unique, non-invasive holistic approach to address adhesive capsulitis. This study, will be conducted as a randomized clinical trial at Ghurki Trust Teaching Hospital and Hope Rehabilitation Center, it aims to evaluate the effects of Gong's mobilization with and without Niel-Asher technique on shoulder pain, ROM and disability in Adhesive Capsulitis of patients aged 40-60 years. A non-probability convenience sampling method will recruit 46 participants meeting the inclusion criteria only. Participants will be randomly assigned to Group A (Gong's Mobilization) or Group B (Gong's mobilization and and Niel-Asher technique) with interventions given for four weeks. Pain severity will be measured using the Numeric Pain Rating Scale, Range of Motion will be assessed via goniometer, and disability will be evaluated using the SPADI. Statistical analysis using SPSS will compare outcomes between groups at baseline, at two weeks and post-treatment after 4 weeks.
383 studies on the registry are indexed under Bursitis; 111 are open to participants now.
This study's planned enrollment of 46 is close to the median of 44 across 346 interventional studies indexed under Bursitis.
Browse Bursitis studies →Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Gong's Mobilization
Other: Gong's Mobilization · Other: Gong's Mobilization and Niel-Asher technique
It is performed in a side-lying position. * The therapist will stand on the affected side of the patient and push the head of humerus of the affected side in anterior to posterior direction parallel to the joint plane with the palm of his hand, simultaneously, with the other hand, the therapist will push the scapula from posterior to anterior direction realigning and stabilizing the humeral head within correct position. * The patient is asked to quickly and powerfully perform abduction while keeping the elbow straight. Meanwhile, the therapist will keep pressing the humeral head along the long axis of the humerus, maintaining the oscillatory glide in Maitland's grade (III, IV), following the movement of the patient's shoulder during abduction. * The speed of the movement is kept constant by the therapist while maintaining a little distraction at the Glenohumeral joint. * Therapist will accelerate the movement at the end range to gain Glenohumeral ROM.
1\. In Niel-Asher technique, the patient was made to lie sideways and several deep strokes with your hand, from elbow to humeral head were applied. Apply sustained pressure over the embedded nodules or over the fibrous band which you may feel when you move upwards. 2. Apply deep sustained pressure on the tender point over the posterior joint capsule area (teres minor). 3. Perform circumduction of shoulder with bent elbow repeatedly several times from small to large complete circles. 4\. Release the fascia up the long head biceps tendon and move upwards only. Pause on the nodules along the tendon; these are fascial tethering and may be inflamed. As you approach the shoulder, near the biceps tendon joins the capsule, hold the trigger point for up to three minutes until it is completely pain free. 5.In supine lying position, the middle fingers of your hand, presses deeply on the trigger point in the middle of the shoulder blade (infraspinatus)
Shoulder Pain and Disability Index (SPADI)
SPADI is a 13 item Questionnaire to evaluate pain (5items) and disability (8 items) in shoulder joint. The patient is instructed to choose the number that best describes their level of pain and extent of difficulty using the involved shoulder. The pain scale is summed up to a total of 50 while the disability scale sums up to 80. The total SPADI score is expressed as a percentage. A score of 0 indicates best 100 indicates worst. A higher score shows more disability.
Time frame: 6th week
Universal Goniometer (UG)
Universal goniometer is tool in orthopedics used to precisely measure angles at joints. Goniometer demonstrates good intra-rater and inter-rater reliability when used consistently with proper technique. It will measure the ranges at shoulder joint (Abduction, Adduction, Flexion, Extension, Internal rotation, External rotation
Time frame: 6th week
Plan to share: No
Started Dec 2025 (actual). Primary completion is estimated for Jun 2026, 6 months after the start.
Of 217 non-industry interventional studies with no phase under Bursitis, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 17. This study's planned 6 months is below that.
Counting every sponsor, half of 217 studies reached it within 10 months; a quarter within 5 and three quarters within 17.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Riphah International University →